One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Post-Dobbs Challenges in Research and Patient Protections
Aimee N. C. Campbell, PhD, MSW1,2; Shelly F. Greenfield, MD, MPH3,4,5
doi : 10.1001/jamapsychiatry.2024.0598
June 2024, Vol 81, No. 6, Pages 534-634
Medicaid Reentry Section 1115 Demonstration Opportunity
William C. Lieber1; Jade Zhang2; Lauren Brinkley-Rubinstein, PhD3
Digital Mental Health’s Unstable Dichotomy—Wellness and Health
John Torous, MD1; Joseph Firth, PhD2; Simon B. Goldberg, PhD3,4
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety
David B. Yaden, PhD1; Natalie Gukasyan, MD2; Sandeep M. Nayak, MD1
Informed Consent to Psychedelic Treatment—A Work in Progress
Paul S. Appelbaum, MD1
Acupuncture for Combat-Related Posttraumatic Stress Disorder
Michael Hollifield, MD1,2; An-Fu Hsiao, MD, PhD1,3; Tyler Smith, PhD4; Teresa Calloway, MATCM, LAc1,5; Tanja Jovanovic, PhD6; Besa Smith, PhD4; Kala Carrick, MS1; Seth D. Norrholm, PhD6; Andrea Munoz, PsyD1; Ruth Alpert, BA1; Brianna Caicedo, BA1; Nikki Frousakis, PhD1; Karen Cocozza, DACM, LAc7
Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes
Scott T. Aaronson, MD1,2; Andrew van der Vaart, MD, PhD2; Tammy Miller, PsyD1; Jeffrey LaPratt, PsyD1; Kimberly Swartz, BSN1; Audrey Shoultz, BS1; Margo Lauterbach, MD1,2; Harold A. Sackeim, PhD3,4; Trisha Suppes, MD, PhD5,6
Psychomotor Slowing in Psychosis and Inhibitory Repetitive Transcranial Magnetic Stimulation
Sebastian Walther, MD1; Danai Alexaki, MD1; Florian Weiss, MD1; Daniel Baumann-Gama, MMed1; Alexandra Kyrou, MD1; Melanie G. Nuoffer, MSc1,2; Florian Wüthrich, MD1,2; Stephanie Lefebvre, PhD1; Niluja Nadesalingam, PhD1
Lifetime Suicide Attempts in Otherwise Psychiatrically Healthy Individuals
Maria A. Oquendo, MD, PhD1; Melanie Wall, PhD2; Shuai Wang, PhD3; Mark Olfson, MD, MPH2; Carlos Blanco, MD, PhD3
Adolescent Psychedelic Use and Psychotic or Manic Symptoms
Otto Simonsson, PhD1; Miriam A. Mosing, PhD2,3,4,5; Walter Osika, MD, PhD1,6; Fredrik Ullén, PhD2,3; Henrik Larsson, PhD5,7; Yi Lu, PhD5; Laura W. Wesseldijk, PhD2,3,8
Adverse Childhood Experiences and Adult Mental Health Outcomes
Hilda Björk DanÃelsdóttir, MSc1,2; Thor Aspelund, PhD1; Qing Shen, PhD1,2,3,4; Thorhildur Halldorsdottir, PhD5; Jóhanna Jakobsdóttir, PhD1; Huan Song, MD, PhD1,2,6; Donghao Lu, MD, PhD2; Ralf Kuja-Halkola, PhD7; Henrik Larsson, PhD7; Katja Fall, PhD2,8; Patrik K. E. Magnusson, PhD7; Fang Fang, MD, PhD2; Jacob Bergstedt, PhD2; Unnur Anna Valdimarsdóttir, PhD1,2,9
Decoding Suicide Decedent Profiles and Signs of Suicidal Intent Using Latent Class Analysis
Yunyu Xiao, PhD1; Kaiwen Bi, BA2; Paul Siu-Fai Yip, PhD2,3; Julie Cerel, PhD4; Timothy T. Brown, PhD5; Yifan Peng, PhD1; Jyotishman Pathak, PhD1; J. John Mann, MD6,7,8
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents
Mark Olfson, MD, MPH1,2; Chandler McClellan, PhD3; Samuel H. Zuvekas, PhD3; Melanie Wall, PhD1,2; Carlos Blanco, MD, PhD4
Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, MD, JD1,2; Rebecca W. Brendel, MD, JD3; Carmel Shachar, JD, MPH4; I. Glenn Cohen, JD1
A Dynamical Systems View of Psychiatric Disorders—Theory
Marten Scheffer, PhD1; Claudi L. Bockting, PhD2; Denny Borsboom, PhD3; Roshan Cools, PhD4; Clara Delecroix, MSc1; Jessica A. Hartmann, PhD5; Kenneth S. Kendler, MD6; Ingrid van de Leemput, PhD1; Han L. J. van der Maas, PhD3; Egbert van Nes, PhD1; Mark Mattson, PhD7; Pat D. McGorry, PhD8; Barnaby Nelson, PhD8
A Dynamical Systems View of Psychiatric Disorders—Practical Implications
Marten Scheffer, PhD1; Claudi L. Bockting, PhD2; Denny Borsboom, PhD3; Roshan Cools, PhD4; Clara Delecroix, MSc1; Jessica A. Hartmann, PhD5; Kenneth S. Kendler, MD6; Ingrid van de Leemput, PhD1; Han L. J. van der Maas, PhD3; Egbert van Nes, PhD1; Mark Mattson, PhD7; Pat D. McGorry, PhD8; Barnaby Nelson, PhD8
Heritability of Clinically Diagnosed Obsessive-Compulsive Disorder Among Twins
David Mataix-Cols, PhD1; Lorena Fernández de la Cruz, PhD1; Jan C. Beucke, PhD2; Elles De Schipper, PhD1; Ralf Kuja-Halkola, PhD3; Paul Lichtenstein, PhD3; Josep Pol-Fuster, PhD1
Assumptions and Limitations of the Synthetic Control Method
Stephan R. Lindner, PhD1
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety
Eiko I. Fried, PhD1; Ioana A. Cristea, PhD2; Florian Naudet, MD3
Treating Bipolar Depression Using Psilocybin—Validity Threats Regarding Efficacy and Safety—Reply
Scott T. Aaronson, MD1; Andrew van der Vaart, MD, PhD2; Harold A. Sackeim, PhD3
